EP0938313A4 - Verfahren und zusammenstellungen zur behandlung von urininkontinenz durch enantomerisch angereichertes (s)-clidinum - Google Patents

Verfahren und zusammenstellungen zur behandlung von urininkontinenz durch enantomerisch angereichertes (s)-clidinum

Info

Publication number
EP0938313A4
EP0938313A4 EP97932350A EP97932350A EP0938313A4 EP 0938313 A4 EP0938313 A4 EP 0938313A4 EP 97932350 A EP97932350 A EP 97932350A EP 97932350 A EP97932350 A EP 97932350A EP 0938313 A4 EP0938313 A4 EP 0938313A4
Authority
EP
European Patent Office
Prior art keywords
clidinium
compositions
methods
urinary incontinence
enantiomerically enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97932350A
Other languages
English (en)
French (fr)
Other versions
EP0938313A1 (de
Inventor
Vincent L Fabiano
John R Mccullough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0938313A1 publication Critical patent/EP0938313A1/de
Publication of EP0938313A4 publication Critical patent/EP0938313A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97932350A 1996-07-01 1997-06-27 Verfahren und zusammenstellungen zur behandlung von urininkontinenz durch enantomerisch angereichertes (s)-clidinum Withdrawn EP0938313A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2092596P 1996-07-01 1996-07-01
US20925P 1996-07-01
PCT/US1997/011259 WO1998000139A1 (en) 1996-07-01 1997-06-27 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-clidinium

Publications (2)

Publication Number Publication Date
EP0938313A1 EP0938313A1 (de) 1999-09-01
EP0938313A4 true EP0938313A4 (de) 2000-02-23

Family

ID=21801321

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97932350A Withdrawn EP0938313A4 (de) 1996-07-01 1997-06-27 Verfahren und zusammenstellungen zur behandlung von urininkontinenz durch enantomerisch angereichertes (s)-clidinum

Country Status (2)

Country Link
EP (1) EP0938313A4 (de)
WO (1) WO1998000139A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
CA2536401C (en) * 2003-11-04 2011-08-30 Shire Laboratories Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4644003A (en) * 1985-04-03 1987-02-17 Research Corporation 3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
HAURI D.: "[Incontinence of urine: Possibilities for pharmacotherapy].", MEDIZINISCHE MONATSSCHRIFT FUR PHARMAZEUTEN, (1984) 7/8 (233-239). CODEN: MMPHDB, XP000863460 *
KOPPENHOEFER B. ET AL: "Separation of enantiomers of drugs by capillary electrophoresis I..gamma.-Cyclodextrin as chiral solvating agent.", JOURNAL OF CHROMATOGRAPHY A, (1995) 717/1-2 (181-190)., XP000605057 *
KOPPENHOEFER, BERNHARD ET AL: "Separation of enantiomers of drugs by capillary electrophoresis Part 4: hydroxypropyl-gamma-cyclodextrin as chiral solvating agent", ELECTROPHORESIS (1997), 18(6), 924-930, XP000863400 *
LIN B C (REPRINT) ET AL: "SEPARATION OF DRUG ENANTIOMERS BY CAPILLARY ELECTROPHORESIS ALPHA-CYCLODEXTRIN AS CHIRAL SOLVATING AGENT", CHROMATOGRAPHIA, (JAN 1996) VOL. 42, NO. 1-2, PP. 106-110. ISSN: 0009-5893., vol. 42, no. 1/2, 1996, DALIAN INST CHEM PHYS, ZHONG SHAN RD 161, DALIAN 116012, PEOPLES R CHINA (Reprint);CHINA PHARMACEUT UNIV, NANJING 250009, PEOPLES R CHINA; UNIV TUBINGEN, INST ORGAN CHEM, D-72076 TUBINGEN, GERMANY, pages 106 - 110, XP000863359 *
LIN, BINGCHENG ET AL: "Investigation of 123 chiral drugs by cyclodextrin-modified capillary electrophoresis", LC-GC (1997), 15(1), 40, 44-46, XP000863469 *
See also references of WO9800139A1 *
YURDAKOK M ET AL: "Treatment of enuresis: a study with imipramine, amitriptyline, chlordiazepoxide- clidinium and piracetam.", TURKISH JOURNAL OF PEDIATRICS, (1986 JUL-SEP) 28 (3) 171-5., XP000863478 *

Also Published As

Publication number Publication date
EP0938313A1 (de) 1999-09-01
WO1998000139A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
PL330752A1 (en) Pharmaceutical agent for treating urinary incontinence
ZA963844B (en) Seed treatment composition and method
EP0973513A4 (de) Zusammenstellungen und verfahren zur behandlung von knochenmangelerscheinungen
IL117956A0 (en) Use of alpha1l-agonists for treating urinary incontinence
EP0871494A4 (de) Zusammensetzungen und methoden zur behandlung von tumorzellen
AU5439996A (en) Compositions and methods for treating pain
ZA978427B (en) Method of treating urinary incontinence
HK1031174A1 (en) Compositions and methods for treating diabetes
AU8480098A (en) Apparatus and method for treating female urinary incontinence
IL143488A0 (en) Cancer treatment composition and method using natural plant essential oils
IL115405A0 (en) Compositions and methods for treating mast-cell mediated conditions
AU6872498A (en) Method and composition for skin treatment
AU9214398A (en) Compositions and methods for treating water
IL129272A0 (en) Method and composition for treating skin damage
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
EP0909163A4 (de) Verfahren und mittel zur behandlung der harninkontinenz unter hauptsaechlicher verwendung des (s,r)-glycopyrrolat enantiomers
AU3401199A (en) Method and composition for treating psoriasis
AU3909897A (en) Apparatus for treating incontinence in females
EP0759745A4 (de) Verfahren und präparate zur erhöhung der calciumaufnahme
AU5594398A (en) Methods and compositions for preventing and treating bone loss
EP0835092A4 (de) Zusammensetzung für-, und behandlung von kahlheit
EP0909170A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (s)-tridihexethyl
EP0938313A4 (de) Verfahren und zusammenstellungen zur behandlung von urininkontinenz durch enantomerisch angereichertes (s)-clidinum
AU5791698A (en) Methods and compositions for preventing and treating bone loss
EP0957916A4 (de) Methoden und zusammenstellungen zur behandlung der harninkontinenz mittels durch enantionmorphismus angereichertem (r)-clidinium

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000111

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030103